BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8033084)

  • 1. Genomic instability of microsatellite repeats and mutations of H-, K-, and N-ras, and p53 genes in renal cell carcinoma.
    Uchida T; Wada C; Wang C; Egawa S; Ohtani H; Koshiba K
    Cancer Res; 1994 Jul; 54(14):3682-5. PubMed ID: 8033084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways.
    Lax SF; Kendall B; Tashiro H; Slebos RJ; Hedrick L
    Cancer; 2000 Feb; 88(4):814-24. PubMed ID: 10679651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replication error phenotype and p53 gene mutation in lymphomas of mucosa-associated lymphoid tissue.
    Peng H; Chen G; Du M; Singh N; Isaacson PG; Pan L
    Am J Pathol; 1996 Feb; 148(2):643-8. PubMed ID: 8579126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent p53 gene mutations in serrated adenomas of the colorectum.
    Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E
    J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microsatellite instability and other molecular abnormalities in non-small cell lung cancer.
    Fong KM; Zimmerman PV; Smith PJ
    Cancer Res; 1995 Jan; 55(1):28-30. PubMed ID: 7805035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma.
    Isa T; Tomita S; Nakachi A; Miyazato H; Shimoji H; Kusano T; Muto Y; Furukawa M
    Hepatogastroenterology; 2002; 49(45):604-8. PubMed ID: 12063950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
    Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
    Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P53 mutations in colorectal cancer from northern Iran: Relationships with site of tumor origin, microsatellite instability and K-ras mutations.
    Mahdavinia M; Bishehsari F; Verginelli F; Cumashi A; Lattanzio R; Sotoudeh M; Ansari R; Semeraro D; Hormazdi M; Fakheri H; Rakhshani N; De Lellis L; Curia MC; Cama A; Piantelli M; Malekzadeh R; Iacobelli S; Mariani-Costantini R
    J Cell Physiol; 2008 Aug; 216(2):543-50. PubMed ID: 18330889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of the K-ras and p53 genes and microsatellite instability in sporadic colorectal carcinomas.
    Hasegawa A; Fukushima T; Mashiko M; Nakano K; Suzuki S; Endo Y; Ohki S; Hatakeyama Y; Koyama Y; Inoue N; Takebayashi Y; Sekikawa K; Takenoshita S
    Anticancer Res; 2004; 24(3b):2047-52. PubMed ID: 15274399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.
    Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K
    Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of microsatellite marker, AP-PCR and CGH studies in primary renal cell carcinoma.
    Hoefling C; Schmidt H; Meinhardt M; Lohse A; Taubert H; Fuessel S; Schmidt U; Schuster K; Baretton G; Wirth MP; Meye A
    Int J Mol Med; 2004 Jun; 13(6):835-42. PubMed ID: 15138621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple detection of genetic alterations in tumors and stool.
    Rengucci C; Maiolo P; Saragoni L; Zoli W; Amadori D; Calistri D
    Clin Cancer Res; 2001 Mar; 7(3):590-3. PubMed ID: 11297253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
    Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
    Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of the p53 tumour suppressor gene occurs preferentially in the chromophobe type of renal cell tumour.
    Contractor H; Zariwala M; Bugert P; Zeisler J; Kovacs G
    J Pathol; 1997 Feb; 181(2):136-9. PubMed ID: 9120715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoplasia of the ampulla of Vater. Ki-ras and p53 mutations.
    Scarpa A; Capelli P; Zamboni G; Oda T; Mukai K; Bonetti F; Martignoni G; Iacono C; Serio G; Hirohashi S
    Am J Pathol; 1993 Apr; 142(4):1163-72. PubMed ID: 8475992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of mutations of ras and p53 in benign and malignant thyroid tumors from children exposed to radiation after the Chernobyl nuclear accident.
    Nikiforov YE; Nikiforova MN; Gnepp DR; Fagin JA
    Oncogene; 1996 Aug; 13(4):687-93. PubMed ID: 8761289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 mutations and microsatellite instability in sporadic gastric cancer: when guardians fail.
    Strickler JG; Zheng J; Shu Q; Burgart LJ; Alberts SR; Shibata D
    Cancer Res; 1994 Sep; 54(17):4750-5. PubMed ID: 8062274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer.
    Yamaguchi K; Chijiiwa K; Torato N; Kinoshita M; Tanaka M
    Am J Gastroenterol; 2000 Aug; 95(8):1939-45. PubMed ID: 10950039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.